iarjmcrIARJMCRIARJMCR2709-3220https://doi.org/10.47310/iarjmcr.2021.v02i01.018Treatment of Retinal Vein OcclusionAyadWalidKhalidAhmedNezar AbdulHameedHaqiIsma'elHummadiThis study evaluated the treatment outcomes of retinal vein occlusion (RVO). In a study that lasted for 6 months. 38 patients with low vision due to MC with RCVO (9 patients) or RCVO (29 patients) participated in one eye. The age of the patients was 46-72 years, and the average age was 52 years. Immature cataracts were diagnosed at old age in 14 patients with concomitant eye diseases. The maximum corrected visual acuity (MCVA) was 0.06-0.4, the retinal thickness in the central region was ≥430 μm, and the duration of macular edema was from 4 weeks to 9 months. All patients underwent ophthalmological examination prior to implantation, after 1 and 7 days, 1, 4, and 6 months. After the injection. At each follow-up examination, visual acuity was determined according to the Sivtsev-Golovin table, ocular tension measurement, and ophthalmoscopy microscopy using a 78 dioptric aspherical lens or Goldman contact lenses. Retinal thickness was estimated using OCT "SPECTRALIS" OCT Heidelberg Engineering, initially in microns, size - in mm3, as well as retinal structure - thickness and cystic changes, subepithelial detachment, after 1, 4, 6 months. With a decrease in OZ observed after the treatment effect in the form of an increase in BCVA was achieved in the first months. Fundus imaging was performed using a seven-field computer suture of the retina (Visucam 500 ZEISS) before implantation and 6 months later; At a period of 10-14 weeks, PAH was performed in the retina according to the standard technique. Statistical Analysis: The data were processed using the Statistical program using the paired Student's t-test for related samples. Results with an error of less than 5% (p <0.05) were considered significant.